Merck (MRK) Sales of Property, Plant and Equipment (2009)

Merck (MRK) Sales of Property, Plant and Equipment (2009) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Sales of Property, Plant and Equipment (Qtr)
1	Johnson & Johnson	652.20 Bn	631.44 Bn	17.26 Bn	63.00 Mn
2	AbbVie	469.51 Bn	462.94 Bn	12.70 Bn	-
3	Merck	376.81 Bn	369.67 Bn	12.21 Bn	-
4	Novartis Ag	303.04 Bn	295.35 Bn	11.24 Bn	26.00 Mn
5	Astrazeneca	257.61 Bn	252.71 Bn	12.86 Bn	4.00 Mn
6	Amgen	237.37 Bn	223.38 Bn	7.24 Bn	-
7	Gilead Sciences	181.73 Bn	178.55 Bn	6.22 Bn	-
8	Pfizer	159.66 Bn	147.96 Bn	10.94 Bn	-
9	Gsk	106.24 Bn	102.07 Bn	8.24 Bn	4.03 Mn
10	Sanofi	55.07 Bn	47.69 Bn	10.79 Bn	363.82 Mn

Download Data

Date	Value
Sep 30, 2009	44.00 Mn
Sep 30, 2009	44.00 Mn